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Background: Recent evidence suggests an important role of protein phosphatase 4 (PP4C) in the progression of
several cancers, including breast cancer, lung cancer and pancreatic ductal adenocarcinoma. However, the contribution
of PP4C to colorectal carcinoma (CRC) remains elusive.
Methods: The expression of PP4C in CRC tissues compared with matched non-tumor tissues and CRC cells was
detected using quantitative RT-PCR, immunohistochemistry and western blotting assays. Through univariate and
Kaplan-Meier analysis, we correlated the PP4C expression with clinicopathological features and patient survival. A
series of experiments, including cell proliferation, lentiviral infection, cell invasion and MMP gelatinase activity
assays, were performed to investigate the underlying mechanisms. Through further experiments, tumor growth
and metastasis were evaluated in vivo using a xenogenous subcutaneously implant model and a tail vein metastasis
model.
Results: In the present study, we found that PP4C expression is frequently increased in human CRC and that the
upregulation of PP4C correlates with a more invasive tumor phenotype and poor prognosis. The ectopic expression of
PP4C promoted CRC cell proliferation, migration and invasion in vitro and tumor growth and lung metastasis in vivo.
Silencing the expression of PP4C resulted in the inhibition of cell proliferation and invasion. Further investigations
showed that phosphorylated Akt (p-AKT) is required for the PP4C-mediated upregulation of MMP-2 and MMP-9, which
promotes cell invasion.
Conclusions: Our data suggested a potential role of PP4C in tumor progression and provided novel insights into the
mechanism of how this factor positively regulated cell proliferation and invasion in CRC cells.
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Colorectal cancer (CRC) is a common cancer and a lead-
ing cause of cancer-related mortality and morbidity world-
wide. The incidence of CRC is increasing [1,2]. The
current standard treatment for patients with CRC is
surgical resection followed by adjuvant chemotherapy.
However, the overall survival rate of patients varies from
90% to less than 5% due to different stages in the disease
progress at diagnosis [3,4]. Post-operative recurrence and
metastasis play a crucial role in the progression of CRC.* Correspondence: lxx1149@163.com; caisanjuncsj@163.com
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unless otherwise stated.However, the multiple alterations of molecular mecha-
nisms that lead to abnormal changes in signaling pathways
and malignant behaviors remain unclear [5,6]. Therefore,
understanding the key factors in these processes is crucial
for finding new therapeutic molecular targets of CRC.
Accumulating evidence has demonstrated that aberrant
gene expression leads to high tumorigenic properties by
affecting the control of growth, apoptosis, differentiation,
migration and invasion [7-9]. Protein phosphatase 4
(PP4C), a member of the PPP family of serine/threonine
protein phosphatases, contributes to the nucleation,
growth and maturation of the centrosome during cell
division [10-12]. Studies have demonstrated that PP4C
played diverse cellular functions in different organ oris an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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duces the colony-forming ability and induces apoptosis
of mouse thymoma cells and HEK 293 T cells [13,14].
However, increasing evidence indicates the important
role of PP4C in human tumorigenesis. Suppressing the
expression of PP4C induces apoptosis in A549 and HeLa
cells [15]. Increased expression of PP4C has been ob-
served in breast cancer, lung cancer and pancreatic ductal
adenocarcinoma [16,17]. In addition, the overexpression
of PP4C regulates the NF-κB, JNK and m-TOR pathway
[18-20]. These studies indicate that PP4C plays an import-
ant role in cancer development. Despite the increased
overexpression of PP4C in human cancers, the molecular
mechanism underlying the role of PP4C in CRC remains
to be elucidated.
AKT has been reported to play important roles in a
variety of cellular processes that are considered to be
cancer hallmarks [21,22]. Several studies have reported
that the AKT proto-oncogene is overexpressed and re-
quired for cell proliferation, angiogenesis, invasion and
metastasis in CRC [23,24]. It is tempting to speculate
that the upregulation of PP4C expression in CRC may be
responsible for the increased AKT-mediated responses
resulting in cell survival and invasion, a phenomenon that
is known to occur in cancer.
In the present study, we analyzed the PP4C expression
levels in CRC tissues compared with paired non-tumor
tissues and evaluated the correlations between the PP4C
level and clinicopathological features. The overexpression
of PP4C promoted cancer cell growth and invasion andFigure 1 PP4C was overexpressed in CRC tissues and cell lines. (A) The PP4C
colorectal tissues was determined by qRT-qPCR. (B) Representative images sh
and colorectal cancer (right) (Original magnification, 100×). (C) Western blotti
p < 0.01.markedly increased the MMP-2/MMP-9 activities through
a PI3K/AKT-dependent signaling pathway. This study
provides the first demonstration that the overexpres-
sion of PP4C promotes tumorigenesis and lung metas-
tasis in vivo.
Results
PP4C is upregulated in colorectal cancer tissues and cell
lines
Previous studies have indicated that the expression of
PP4C is upregulated in tumors of different origins, including
breast cancer, lung cancer and pancreatic ductal adenocar-
cinoma [16,17]. To explore the expression of PP4C in CRC,
we assessed the mRNA levels of PP4C in a cohort of 92
CRC patients with paired adjacent non-tumorous tissue by
qRT-PCR. The results revealed that the mRNA expression
level of PP4C was significantly upregulated in tumor tissues
compared with the level in matched non-tumor tissues
(Figure 1A). To confirm this observed upregulation at
protein level, we detected the PP4C expression levels
using immunohistochemistry. As shown in Figure 1B, rep-
resentative immunohistochemical staining results demon-
strated that the PP4C protein expression in the tissue
samples adjacent to CRC tumors was negative or low but
significantly higher in the CRC tumors.
To further examine whether CRC cells present elevated
PP4C expression levels, we compared the expression of
PP4C among an immortalized intestinal epithelial cell line
(HIEC) and CRC cell lines (SW480, HT29, SW620 and
LOVO) at both the mRNA and protein levels. Interestingly,mRNA expression in CRC specimens and paired adjacent non-cancer
ow PP4C expression in normal tissues adjacent to colorectal tissue (left)
ng analysis of PP4C expression in five CRC cell lines. ** represents
Table 1 Associations between PP4C expression levels and
clinicopathologic features of colorectal cancer patient
Clinicopathologic Variables PP4C expression P
N Negative/Low High
Gender 0.403
Female 59 34 25
Male 33 17 16
Age, y 0.251
≤50 34 20 14
>50 58 31 27
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PP4C was significantly higher in the more tumorigenic and
invasive SW620 and LOVO cell lines. PP4C was lower in
the less tumorigenic and noninvasive SW480 and HT29
cell lines and the normal intestinal epithelial cell line HIEC
(Figure 1C). Consistently, qRT-PCR further confirmed the
results from Western blotting analysis (Figure 2). Taken to-
gether, these data provide the initial evidence that PP4C is
significantly upregulated in CRC tissues, indicating that
PP4C may be associated with increased tumorigenicity
and/or invasiveness, which play a crucial role in CRC.Tumor location 0.256
Colon 42 26 16
Rectum 50 25 25
Differentiation 0.413
Well 27 14 13
Moderately 47 29 18
Poorly 18 8 10
Lymph node metastasis 0.0013*
Yes 27 8 19
No 65 43 22
Vascular invasion 0.0029*
Yes 28 9 19
No 64 42 22
Distant metastasis 0.0081*
Yes 11 2 9
No 81 49 32
AJCC stage 0.0108*
I-II 36 26 10
III-IV 56 25 31
Abbreviations: AJCC, American Joint Committee on Cancer (AJCC). *Statistically
significant, P <0.05.The expression level of PP4C is associated with
clinicopathological features and prognosis in patients
with colon cancer
The observed upregulated expression of PP4C in CRC
prompted us to further investigate the clinical relevance
of PP4C in the progression of CRC. The potential correla-
tions of PP4C expression with a few clinicopathological
parameters (Table 1) were examined in the patients. PP4C
overexpression was associated with lymph node metastasis
(P = 0.0013), vascular invasion (P = 0.0029), distant metas-
tasis (P = 0.0081) and Dukes’ stage (P = 0.0048). However,
no associations were found between PP4C expression and
other clinical features, including age, gender, tumor lo-
cation and tumor differentiation. Furthermore, Kaplan-
Meier analysis using the log-rank test was performed,
and the results showed that patients with high PP4C ex-
pression had a shorter median survival time of 60.4
months. Patients with low PP4C expression had a median
survival time of 87.2 months (P = 0.032; Figure 3). Besides,
multivariate analysis showed that PP4C expression served
as an independent prognostic indicator for overall survival
(OS) (Table 2).Figure 2 PP4C expression was determined in an immortalized human
intestinal epithelial cell line (HIEC) and various CRC cell lines by real-time
PCR analysis.
Figure 3 Increased PP4C expression was significantly associated with
the overall survival (OS) of CRC patients. The data were analyzed using
Kaplan-Meier survival analysis between patients with high PP4C
expression and low PP4C expression according to the intensity scores.
Table 2 Multivariate analysis for OS
Variables OS P
HR (95%CI)
Gender (Male vs Female) 0.56 (0.42-1.47) 0.264
Age (year, #0 vs >50) 0.58 (0.73-1.92) 0.227
Tumor location (colon vs rectum) 0.84 (0.86-1.46) 0.205
Lymph node metastasis (Yes vs No) 2.44 (1.69-5.42) 0.016*
Vascular invasion (Yes vs No) 2.27 (1.86-2.97) 0.035*
Distant metastasis (Yes vs No) 7.69 (3.27-16.38) <0.001*
AJCC stage (I-II vs III-IV) 1.56 (1.21-4.85) 0.008*
PP4C expression (low vs high) 1.24 (1.02-3.59) 0.028*
Abbreviations: OS, overall survival; HR, hazard ratio; CI, Confidence interval.
*Statistically significant, P <0.05.
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migration, whereas PP4C silencing inhibits CRC cell
growth and invasion
To determine whether PP4C possesses an oncogene func-
tion, PP4C was stably overexpressed through a lentiviral
vector system in the SW480 and HT29 cell lines with low
endogenous PP4C levels. We confirmed the PP4C expres-
sion levels through qRT-PCR (Figure 4) and Western blot-
ting analysis (Figure 5A). To investigate whether PP4C
plays a direct functional role in facilitating tumor cell
growth and invasion in CRC cells, the cell proliferation
was determined by CCK-8. The results showed that the
overexpression of PP4C significantly promoted cell prolifer-
ation compared with the control cells (transfected with the
vector control; Figure 5B and C). An invasion assay was
performed to examine the invasive capability of cancer
cells with upregulated PP4C. Increased invasion was ob-
served in the PP4C-overexpressing cells compared with
the vector control group (Figure 5D).
To further explore whether these aggressive cellular
phenotypes were affected by PP4C in CRC cells, PP4C
was knocked down by using a specific shRNA. Effective
PP4C silencing was chosen for further experimentsFigure 4 PP4C mRNA expression were measured through real-time
PCR in SW480 and HT29 cells transfected with PP4C.because it presented a better knockdown efficiency in
both SW620 and LOVO cells and was denoted shPP4C
(Figure 5E) Silencing PP4C in SW620 and LOVO cells led
to a significant inhibition in cell proliferation (Figure 5F
and G). In addition, Matrigel™ invasion assay showed
that the knockdown of PP4C markedly decreased the in-
vasiveness in SW620 and LOVO cells (Figure 5H). Three
different shRNA constructs were used, and the knock-
down efficiency was measured by Western blotting
analysis (Figure 6).These results suggested that PP4C
significantly promotes cell proliferation and invasion
in CRC cells.
PP4C medicates cell migration and invasion by increasing
the expression levels of MMP-2 and MMP-9
To further investigate the potential molecular targets of
PP4C with implication of metastasis in colorectal cancer,
the expression of genes involved in tumor invasion were
examined in a targeted manner. MMPs, particularly
MMP-2 and MMP-9, have been frequently implicated
associated with CRC invasion and are important in the
invasive and metastatic processes [25-27]. The correlation
between overexpressed PP4C-incuded cell invasion and the
expression and activity of MMP-2 and MMP-9 were de-
termined. Western blot indicated that the overexpression
of PP4C increased MMP-2 and MMP-9 (Figure 7A). Add-
itionally, the protein levels of MMP-2 and MMP-9 were
significantly decreased when PP4C was knocked down by
shRNA in SW620 and LOVO cells PP4C (Figure 7B). Con-
sistent with our previous results, MMP gelatinase activity
assay showed that the activities of MMP-2 and MMP-9
were significantly increased in PP4C-overexpressing SW480
and HT29 cells compared with the vector control group
(Figure 7C and D).
To further examine the potential contribution of MMP-2
and MMP-9 in the PP4C-induced invasion of CRC cells,
the gelatinase activities were blocked using the general
MMP inhibitor GM6001 for both MMP-2 and MMP-9.
Results indicated that the inhibition of MMP-2 and
MMP-9 significantly blocked the cell invasion enhanced
by PP4C overexpression (Figure 7E). Taken together, these
results demonstrated that PP4C promotes cell invasion
through mediating the expressions and activities of MMP-
2 and MMP-9.
PI3K/Akt signaling pathway is required for the PP4C-induced
cellular invasion and activities of MMP-2 and MMP-9 in CRC
cells
Because PI3K/Akt has been reported to regulate MMP-2
and MMP-9 expression, we investigated the effects of ec-
topic PP4C expression on the expression of p-Akt (Ser473),
which is critical for the function and activity of AKT. As
shown in Figure 8A, Overexpression of PP4C increased p-
AKT protein expression (Figure 8A), whereas depletion of
Figure 5 PP4C regulated CRC cell proliferation and invasion. (A) Western blotting analysis of PP4C in SW480 and HT29 cells transfected with PP4C or a
vector control. (B, C) Effect of PP4C overexpression on cell proliferation was evaluated by CCK-8 assay [(B) SW480 and (C) HT29]. (D) Representative
micrographs of invasion assay of the indicated cells at 24 h. (E) Western blotting analysis of PP4C in SW620 and LOVO cells transfected with shPP4C or a
negative control. (F, G) Proliferation rates of cell sublines detected by CCK-8 assay after PP4C knockdown [(F) SW480 and (G) HT29]. (H) Representative
micrographs of the indicated cells grown for 24 h on Matrigel in the invasion assay (Original magnification, 100× for D and H). The data are shown as
the means ± SD of three independent experiments. *P < 0.05, **P < 0.01.
Li et al. Molecular Cancer  (2015) 14:95 Page 5 of 13PP4C decreased p-AKT (Ser473) protein expression in both
SW620 and LOVO cells (Figure 9). However, the manipula-
tions of PP4C levels had little effect on the expression ofthe total protein expression level of AKT (Figures 8A and
9). As expected, PP4C silencing significantly decreased the
activities of MMP-2 and MMP-9 (Figure 9).
Figure 6 Knockdown efficiency was shown after treatment of PP4C shRNA in SW620 and LOVO cell lines, which presented high endogenous
PP4C expression.
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naling to PP4C-induced cell invasion and MMP-2 and
MMP-9 expression, Ly294002, a PI3K inhibitor, was
used to inhibit the activation of PI3K/AKT pathway
and PP4C-induced AKT activation. Furthermore, PP4C-
induced high MMP-2 and MMP-9 expression levels
(Figure 8A) and activities (Figures 8B and C) in SW480
and LOVO cells were reversed by targeted inhibition
using Ly294002. Consequently, Ly294002 abolished the
effect of PP4C overexpression on SW480 and HT29 cell
invasion (Figure 8D). Consisted with above results,Figure 7 MMP-2 and MMP-9 were essential for mediating PP4C-induced c
were detected by immunoblotting in SW480 and HT29 cells overexpressing P
and LOVO cells expressing lentiviral PP4C shRNA. (C, D) Conditioned med
and evaluated using the MMP gelatinase activity assay. (E, F) SW480 and HT2
GM6001 (25), a MMP-2 neutralizing antibody (Anti-MMP2) or a MMP-9 neutra
determined using Matrigel invasion assay. *P < 0.05 and **P < 0.01 compareddepletion of PP4C decreased p-AKT (Ser473) protein
expression in both SW620 and LOVO cells (Figure 9).
Similarly, PP4C silencing significantly decreased the
activities of MMP-2 and MMP-9 (Figure 9). We next
used MK-2206, an Akt inhibitor, to block AKT activity.
As shown in Figure 10, blocking Akt significantly de-
creased the effect on PP4C stimulation of MMP-2 and
MMP-9 expression and activity. Taken together, these
findings indicated that PP4C induces CRC cell invasion,
production and activation of MMP-2 and MMP-9
through activation of the PI3K/AKT pathway.ell invasion. (A) The protein expression levels of MMP-2 and MMP-9
P4C. (B) Immunoblotting of MMP-2 and MMP-9 expression in SW620
ium from SW480 and HT29 cells overexpressing PP4C was collected
9 cells overexpressing PP4C were pretreated with the MMP inhibitor
lizing antibody (Anti-MMP9) for 30 min, and the cell invasion was then
with the vector controls.
Figure 8 Involvement of the PI3K/AKT pathway in PP4C-induced MMP-2 and MMP-9 expression and activation and cell invasion. (A) Levels of p-AKT,
T-AKT, MMP-2 and MMP-9 were evaluated in SW480 and HT29 cells after the indicated treatment. (B, C) The MMP gelatinase activity was determined
after the indicated treatment. (D) Matrigel cell invasion was evaluated in SW480 and HT29 cells transfected with either vector control or PP4C followed
by treatment with the PI3K inhibitor Ly294002 (25 μmol).
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growth and metastatic potential in vivo
The in vitro experiments revealed that PP4C improves the
proliferation and invasion of CRC cells. Whether PP4C
can affect tumorigenicity and tumor metastasis in vivo
was further investigated. The flanks of four-week-old nude
mice were injected subcutaneously with SW480-PP4C
cells that were stably expressing PP4C or vector-
transfected cells. The sizes of growing tumors were moni-
tored weekly for four weeks. All of the mice were sacrificed
four weeks after inoculation and tumor mass was weighed.
The sizes of tumor from the SW480-PP4C group were sig-
nificantly larger than those from the SW480-vector group.
The average tumor weights were similar (Figure 11A). To
further confirm the relationship by which PP4C promote
tumor growth and metastasis via upregulation of MMP-2
and MMP-9, we evaluated the expression levels of PP4C,MMP-2 and MMP-9 in vivo. As shown in Figure 11B,
Western blotting showed that PP4C overexpression signifi-
cantly induced MMP-2 and MMP-9 expression. Addition-
ally, SW480-PP4C cells or vector-transfected cells were
injected into the mice via the tail vein and the tumor for-
mation in the lungs was assessed five weeks after inocula-
tion. The number and size of the lung metastatic nodules
was markedly increased in the SW480-PP4C group com-
pared with the vector controls (Figure 11C). These results
suggested that PP4C significantly promotes tumor growth
and that the overexpression of PP4C markedly enhances
the metastasis of SW480 cells in vivo, indicating that PP4C
plays a positive role in CRC tumorigenicity and metastasis.
Discussion
Previous studies have shown that PP4C is overexpressed
in breast cancer, lung cancer and pancreatic ductal
Figure 9 Effect of PP4C knockdown on AKT signaling molecules in CRC cells involved in MMP gelatinase activity. (A) Western blotting analysis of p-AKT
and T-AKT expression was analyzed in PP4C-silenced SW620 and LOVO cells. (B, C) The MMP gelatinase activity was determined after PP4C silencing.
Figure 10 MK-2206 blocked PP4C-induced MMP-2 and MMP-9 expression and activation. (A) Levels of p-AKT, T-AKT, MMP-2 and MMP-9 were
evaluated in SW480 and HT29 cells after the indicated treatment. (B, C) The MMP gelatinase activity was determined after the indicated treatment.
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Figure 11 PP4C promoted CRC cell tumorigenicity and invasiveness of SW480 cells in vivo. (A) Representative photographs of tumors derived
from SW480-PP4C or SW480-vector control cells in nude mice. The bar graphs showed the average tumor weight (gram). (B) At the end of the
experiment, the expression of proteins of PP4C, MMP-2 and MMP-9 were determined in tissues from mice bearing SW480 xenograft tumors. (C)
The number of tumor nodules and foci in the lungs was counted based on hematoxylin and eosin staining (Original magnification, 200 × for B).
The values represent the means ± SD from 18 mice. **P < 0.01 (Student’s t test).
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nosis [16,17]. However, little is known regarding its ex-
pression pattern and exact mechanism in CRC. This study
demonstrated that PP4C gene expression was increased in
CRC and correlated with lymphatic nodes, distant metas-
tasis and with overall patient survival.
To explore the possible biological functions of PP4C in
CRC, we first assessed the expression of PP4C in CRC tis-
sues and CRC cell lines at the mRNA and protein levels.
Our data showed that PP4C is markedly overexpressed
in CRC tissues compared with their adjacent non-
tumorous tissues. The expression levels of PP4C in
CRC cell lines further supported the results from the
tissue samples. Interestingly, there was a significant
positive correlation between PP4C expression and aggres-
sive clinical behaviors in CRC. In addition, CRC patients
with a high level of PP4C expression showed poor overall
survival, as determined by a Kaplan-Meier survival assay.
It has been previously shown that PP4C is involved in
mediating microtubule growth, cell migration and centro-
some maturation in mitosis and meiosis [11,12]. Numer-
ous studies have also shown that PP4C regulates the NF-κB,
JNK and m-TOR pathway and is associated with cisplatin
sensitivity [14,18,19]. These data demonstrated that PP4C
may play an important role in cancer progression. Con-
sistent with these results, our results suggested that PP4C
acts as an oncogene in CRC. To further elaborate the
biological functions in CRC, we examined the effect of
PP4C on SW480 and HT29 cell proliferation and invasive
activity using CCK-8 and Matrigel™ Invasion Chambers,respectively. As expected, the overexpression of PP4C
promoted cell proliferation and invasion, whereas PP4C
silencing inhibited cell proliferation and invasion in
SW620 and LOVO cells, which present high endogen-
ous PP4C levels. In addition, our data indicated that the
overexpression of PP4C notably promotes the ability of
CRC cells to form tumors and lung colonies in the in vivo
model. These results were consistent with previous studies
regarding the expression of PP4C in CRC tissues, which
indicated that it may play a crucial role in phenotype be-
havior in a clinical study.
Cancer invasion and metastasis are multiple steps in-
volving genetic alterations and deregulation of multiple
signaling pathways [21,28,29]. The high mortality rate
attributes to extensive local tumor invasion and distant
metastasis [30]. Previous studies demonstrated that de-
pletion of PP4C in HEK293 cells resulted in severely
decreased cell migration and suggested that PP4C com-
plexes may coordinate centrosome maturation and cell
migration via regulation of Rho GTPases [31]. We then
focused on the effects of PP4C on the invasion and me-
tastasis in CRC cells. Increasing evidence suggests that
MMPs, particularly MMP-2 and MMP-9, are upregulated
in cancer cells and play a critical role in these processes
[25,32,33]. In this study, we showed that upregulation of
PP4C enhanced the expression and secretion of MMP-2
and MMP-9. In contrast, the knockdown of PP4C by
shRNA reduced the expression and secretion of MMP-2
and MMP-9. Furthermore, the blockade of MMP-2
and/or MMP-9 reversed the stimulus effects of PP4C
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to explain the underlining mechanisms, which contribute
to the alteration of MMPs induced by PP4C. Furthermore,
PI3K/AKT contributes to extracellular matrix destruction
by increasing the production of MMP-2 and MMP-9 in
many cancers [27,34,35]. It remains to be further investi-
gated whether PP4C utilizes the same pathway for its ef-
fects on cell motility and invasion and also its effects on
the expression and activation of MMP-2 and MMP-9. In
this study, the phosphorylation of AKT was increased in
PP4C-overexpressing SW480 and HT29 cells and de-
creased in PP4C-knockdown SW620 and LOVO cells. Ex-
tensive studies have shown that the inhibition of PI3K/
AKT signaling with Ly294002 and MK-2206 abrogated cell
invasion induced by PP4C and the expression and activ-
ities of MMP-2 and MMP-9. Taken together, these results
suggested that the PI3K/AKT axis could be a potential
oncogenic mechanism, in which PP4C contributes to the
upregulation of MMP-2 and MMP-9 and cell invasion.Conclusions
Our results provide the first demonstration that PP4C is
frequently overexpressed in CRC. A higher overexpression
of PP4C is associated with the tumor phenotype and a
worse outcome in CRC patients. PP4C overexpression
promotes cell growth and invasion both in vitro and
in vivo. The mechanisms through which PP4C acts as
an oncogene in CRC involve AKT phosphorylation and
upregulated MMP-2/9 expression. Although our findings
of the complicated mechanisms underlying CRC progres-
sion are limited, the selective overexpression of PP4C in
CRC suggests that PP4C may be an important target for
therapeutic intervention.Methods
Patients and samples
Total samples of 92 CRC tissues and matched adjacent
non-cancer colorectal tissues were collected from patients
received CRC surgery for CRC in Fudan University Can-
cer Hospital (Shanghai, China) from October 2003 to May
2008. Written informed consents were obtained from all
of the patients. The study protocol was approved by the
Clinical Research Ethics Committee of Fudan University
Cancer Hospital. The diagnosis of each case was con-
firmed through H&E slides by two blinded expert pa-
thologists. Immediately upon tumor excision, each tissue
sample was cut into two sections: one was snap-frozen in
liquid nitrogen and stored at -80°C until use (for RNA),
and the other was fixed in 4% formalin and embedded in
paraffin after 24 h (for immunohistochemistry). The clini-
copathological features of these patients were presented
and summarized in Table 1. The patient follow-up data
were updated every six months by telephone. The overallsurvival was the time from the dates of surgery to the time
of last follow-up or of death from CRC.
Cell lines and cell culture
The human CRC cell lines (SW480, HT29, SW620 and
LOVO) and the normal human intestinal epithelial cell
line (HIEC) were purchased from the Culture Collection
of the Chinese Academy of Sciences (Shanghai, China)
and cultured in RPMI-1640 medium (Life Technologies,
Shanghai, China). The HEK 293 T cell line was con-
served in our laboratory and grown in Dulbecco’s modi-
fied Eagle’s medium (Life Technologies, Shanghai, China).
All of the cells were grown in medium supplemented with
10% fetal bovine serum (Gibco, Carlsbad, CA, USA), 100
units/ml penicillin (Life Technologies) and 100 μg/ml
streptomycin (Life Technologies) at 37°C in a humidified
atmosphere containing 5% CO2. The cells were treated
with GM6001 (Chemicon, Temecula, CA, USA), a broad-
spectrum matrix metalloproteinase inhibitor, Ly294002
(Sigma), a selective inhibitor of PI3K, or MK-2206
(Merck, Whitehouse Station, NJ, USA), an Akt inhibitor,
as indicated.
RNA isolation and quantitative RT-PCR (qRT-PCR)
The total RNA from the tissues or cultured cells was ex-
tracted using the TRIzol reagent (Invitrogen, Carlsbad,
CA, USA) according to the manufacturer’s instructions.
Then, 500 ng of total RNA was reverse-transcribed in a
final volume of 10 μl with PrimeScript™ II First-Strand
cDNA Synthesis Kit (TaKaRa, Shiga, Japan). qRT-PCR
was performed using the SYBR Green Master Mix (Roche,
Mannheim, Germany) on an ABI 7900HT Fast Real-Time
PCR System (Applied Biosystems, Foster City, CA, USA)
in triplicate, and non-template controls were run for each
assay under the same conditions. The PCR reaction was
carried out with an initial denaturation step of 95°C for
10 min followed by 40 cycles of 95°C for 15 s and 60°C for
1 min. The primers for PP4C were designed using the Pri-
mer Premier 5.0™ software. The PP4C primer sequences
were (forward) 5′-CTGGATCAGATTCGGACAATCG-3′
and (reverse) 5′-CACCGTCTCATTGAAGTGCCA-3′.
The primer GAPDH sequences were (forward) 5′-AG
CCTTCTCCATGGTGGTGAA-3′ and (reverse) 5′-AT
CACCATCTTCCAGGAGCGA-3′. The results were ana-
lyzed by SDS2.3, and the relative expression was normal-
ized to the expression of glyceraldehyde 3-phosphate
dehydrogenase sequences (GAPDH). The fold change
of PP4C expression was calculated as the mean relative
PP4C gene expression in cancers divided by the mean of
relative KIF2A gene expression in adjacent normal tissues.
Immunohistochemical staining
Formalin-fixed and paraffin-embedded sections with a
thickness of 4 μm were deparaffinized, rehydrated and
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0.01 M sodium citrate buffer (pH 6.0) for 30 min, 3%
H2O2 for 30 min (to block endogenous peroxidase ac-
tivity), and 10% normal goat serum for 30 min (to block
nonspecific staining). The primary antibody, namely
anti-PP4C rabbit polyclonal antibody (OriGene, Rockville,
MD, USA), was applied in a humidified chamber at 4°C
overnight. The sections were then incubated with the
secondary antibody (anti-rabbit antibody) and then with
streptavidin-POD (DAKO, Glostrup, Denmark). The spe-
cific antibody binding was visualized using DAB solution
(DAKO). The tissues were counterstained with hemalaun
solution (DAKO). The primary antibody was replaced by
PBS, which was used as a negative control.
The degree of immunostaining of the sections was
viewed and scored separately by two pathologists who
were blinded to the clinical and histopathologic features.
The scores were assigned to combine the proportion of
positively stained tumor cells and the staining intensity.
The number of positive tumor cells was graded as fol-
lows: ‘-’ (< 5% positive tumor cells), ‘+’ (5-25% positive
tumor cells), ‘++’ (26-50% positive tumor cells), and ‘+++’
(> 50% positive tumor cells). The staining intensity was
recorded as follows: ‘-’ (no staining), ‘+’ (weak staining,
light yellow), ‘++’ (moderate staining, yellowish brown),
and ‘+++’ (strong staining, brown). For survival data
analysis, the samples scored ‘–’ or ‘+’were considered
to present a low level of PP4C expression, and the sam-
ples scored ‘++’ or ‘+++’ were considered to present a
high level of PP4C expression.
Construction of vectors
The full-length CDS of human PP4C was amplified from
the cDNA from HEK293T cells using the following for-
ward and reverse primers: 5′-AAATCTAGAATGGCG
GAGATCAGCGAC-3′ and 5′-AGCGGCCGCCTTCCC
AGCGAAATCATC -3′, respectively. The PCR product was
purified using a PCR purification kit (Qiagen Chatsworth,
CA, USA) and then cloned into the XhaI and BamHI
sites of the pCDH-CMV-MCS-EF1-Puro vector (System
Biosciences, Mountain View, CA, USA). Successful clon-
ing was confirmed by sequencing. To knock down PP4C
expression, short hairpin RNA (shRNA) sequences
specific to PP4C (clone 1-TRCN0000272744, clone 2-
TRCN0000272745, and clone 3-TRCN0000272746) were
purchased from Sigma-Aldrich (Sigma-Aldrich, St. Louis,
MO, USA).
Lentiviral infections
The lentivirus-mediated PP4C packaging vectors or pCDH-
CMV-MCS-EF1-Puro vectors were co-transfected with the
packaging vectors into HEK293T cells using the Fugene
HD Reagent (Roche, Basel, Switzerland) to produce virus
following the manufacturer′s protocol. The PP4C shRNAinsert (shPP4C) or a scrambled sequence (Control) were
co-transfected with Δ8.9 and Vsvg at a ratio of 4:3:2 in
quantity into HEK293T cells using the Fugene HD Reagent
(Roche). Forty-eight hours following transfection, the
infection-competent viral supernatants were collected
and used to infect cells with 8 μg/ml polybrene (Sigma-
Aldrich). The stable clones were then selected in a medium
containing puromycin (5 μg/ml; InvivoGen, San Diego,
CA, USA). Seventy-two hours after infection, the cells were
selected to determine the expression of PP4C before the
experiments.
Cell Count Kit-8 (CCK-8) assay and invasion assays
For the cell proliferation assays, we used the Cell Count-
ing Kit-8 assay (CCK-8; DOJINDO, Tokyo, Japan) accord-
ing to the manufacturer’s instructions. The cells were
seeded into 96-well plates at 4 × 103/well. At the indicated
time, 10 μl of CCK-8 was added to each well, which con-
tained 100 μl of medium. After incubation for 2 h, the op-
tical densities at 450 nm of each well were measured
using a microplate reader (Model 680 Microplate Reader;
Bio-Rad, Richmond, CA, USA). Each sample had four du-
plicate wells and was independently performed in triplicate.
The cell invasion was assessed using 24-well poly-
carbonate filters (membrane pore size 8 μm; Costar,
Cambridge, MA, USA). The upper surface of each in-
sert was coated with 100 μl per well of diluted matrigel
(BD Biosciences, Bedford, MA, USA) (1:5), and the bot-
tom wells were filled with complete medium (10% fetal
bovine serum) as chemoattractant following the manu-
facturer’s protocol. Then, 5 × 104 cells were suspended
in 100 μl of serum-free medium and seeded into the
upper chamber of the 24-well transwell inserts. After
24 h of incubation at 37°C, the non-invading cells were
mechanically removed from the upper surface of the
membrane by wiping with cotton swabs. The cells on
the lower surface of the membrane were fixed with
methanol and stained with 1% crystal violet for 15 min.
The stained cells were counted in five randomly fields
per filter under a microscope (100× magnification). The
experiments were performed in triplicate wells and in-
dependently repeated three times.
MMP gelatinase activity assay
Each group of cells was incubated in serum-free medium
with or without treatment for 24 h. The activities of
MMP-2 and MMP-9 in the conditioned culture super-
natant were determined with the CHEMICON Gelatinase
Activity Assay Kit (Chemicon, Temecula, CA, USA) ac-
cording to the manufacturer’s protocols.
In vivo tumor growth and metastasis study
All of the procedures involving animals were performed
according to the NIH Guide for the Care and Use of
Li et al. Molecular Cancer  (2015) 14:95 Page 12 of 13Laboratory Animals and local institutional ethical guide-
lines for animal experimentation, and the protocols were
approved by the Experimental Animal Ethics Commit-
tee of Fudan University Shanghai Medical College with
permit number 20130148 F. Four-week-old female BALB/c
athymic nude mice were purchased from Slaccas (Slaccas
Laboratory Animal, Shanghai, China). SW480 cells (5 ×
106 cells/mouse) infected with vectors or PP4C in 150 μl
of FBS-free medium were injected subcutaneously into the
flank region of the mice. Tumor measurements were taken
with calipers once weekly, and the tumor volume (V) was
calculated using the following formula: (width2 × length)/2.
For lung metastasis formation, we used six-week-old
nude mice for the tail vein metastasis model. SW480 cells
(5 × 105 cells/mouse) infected with vectors or PP4C in
100 μl of sterile PBS were separately injected into the tail
vein of each mouse. The animals were maintained in a
sterile animal facility and killed six weeks later. The tu-
mors were excised, weighed and measured. The presence
of metastatic lesions in the lungs was determined using a
dissecting microscope.Western blotting
The cells were lysed with RIPA lysis buffer from Cell Signal-
ing Technology (CST, Beverly, MA, USA). Equal amounts
of protein were separated using 10% SDS-PAGE and
transferred to a PVDF membrane (Millipore, Bedford,
MA, USA). The membranes were blocked with 5% non-
fat dry milk in TBST buffer at room temperature for
1 h and then incubated overnight at 4°C with the primary
antibodies against PP4C (OriGene), phospho-AKT (Ser473),
AKT, MMP-2 and MMP-9 (from CST). An antibody to
GAPDH from Kangchen (Kangchen, Shanghai, China) was
used as a loading control. After washing, the membranes
were incubated with HRP-conjugated secondary antibodies
(Kangchen) for 1 h at room temperature and finally visual-
ized using the SuperSignal® West Pico chemiluminescent
substrate kit (Pierce, Rockford, IL, USA). The images were
captured using a luminescent image analyzer LAS-4000
mini (FujiFilm, Tokyo, Japan).Statistical analysis
The significance of the data from patient specimens was
determined by the χ2 test, and the overall survival rates
were determined using the Kaplan-Meier method. The
significance of the in vitro data and in vivo data was de-
termined by a two-tailed independent sample student’s
t-test. ANOVA was employed to compare the differences
among multiple cell lines treated as indicated. The statis-
tical analyses were performed using the GraphPad Prism 5
software package (GraphPad software Inc, San Diego, CA,
USA), and P < 0.05 was considered to be significant.Abbreviations
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